16 security-"https:"-"https:"-"https:"-"https:"-"IFM" positions at Center for Biologics Evaluation and Research (CBER)

FDA Research Opportunity - Detection of Emerging Pathogens that Threaten Blood Safety

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | 8 days ago

-emerging transfusion-transmissible viruses (specifically hepatitis viruses) that threaten the safety of blood and blood-derived products. The project aims to advance in vitro models of infection and in vivo

FDA Fellowship - Understanding the Role of the Manufacturing Microenvironment on the Safety and Efficacy of Cellular Therapies

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 9 days ago

the safety, purity, potency, and effectiveness of biological products including vaccines, blood and blood products, and cells, tissues, and gene therapies for the prevention, diagnosis, and treatment of human

FDA Fellowship - Developing Novel Strategies to Improve Safety, Efficacy and Quality of Gene Therapy Products

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | 9 days ago

applications (BLA) being submitted to the FDA, there is a need to develop innovative analytical methods and regulatory science approaches to comprehensively evaluate the safety, efficacy, and quality

FDA Non-clinical Identification and Mitigation of Safety Risks During the Development and Licensure of Protein-therapeutics

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 15 days ago

to understand the safety consequences of immune responses to neo-epitopes generated due to off-target gene editing. The following articles from our laboratory provide examples of research performed in our group

FDA Fellowship - Immune Globulin Safety and Efficacy in Pregnant and Neonatal Populations

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | 9 days ago

safely, adhering to all the laboratory and personnel safety rules and regulations during appointment activities; Effectively communicate research findings using poster/oral presentations, and written

FDA Computational and Experimental Assessment of Engineered Biotherapeutics: Safety and Regulatory Considerations of Synonymous Gene Recoding

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 9 days ago

Biol, 169718 (2026). https://doi.org:10.1016/j.jmb.2026.169718 Katneni, U.K., Liss, A., Holcomb, D., Katagiri, N., Hunt, R.C., Bar, H., Ismail, A., Komar, A.A. and Kimchi-Sarfaty, C.: Splicing

FDA Postdoctoral Fellowships in Cell and Gene Therapy

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 8 days ago

the regulation of biological and related products including blood, vaccines, allergenics, tissues, and cellular and gene therapies. Research Projects: Project Area 1: Cell and Gene Therapy Safety This project

FDA Research Opportunity - Immune Responses to Influenza Vaccines

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 8 days ago

. The appointment will include training on mode of action and safety of novel adjuvants used to enhance immune responses to multiple vaccines using human derived cells and organoids such as monocytes/macrophages

FDA Fellowship - Cell Membrane Microparticles and Nanoparticles

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 8 days ago

activities of platelet EVs in DMSO cryopreserved platelets (CPP) and other platelet products may significantly impact their safety and efficacy. This project establishes characterization criteria for EVs, as

FDA Prophylactic Vaccine Against Visceral Leishmaniasis Post-doctoral Fellowship

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | 9 days ago

, and cellular and gene therapies. Research Project: The FDA laboratory has been conducting collaborative research on the evaluation of safety and efficacy characteristics of live attenuated Leishmania